Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2025-12-18 00:00:00 ET · period of report 2025-12-16 · accession 0001250379-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-18 | 2025-12-16 | ARWR | PERRY MICHAEL S | Dir | A - Grant | $0.00 | +7,819 | 123.1K | +7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-16 | A | A | 7,819 | $0.00 | 123,059 | D | — | — | (F1) Represents shares underlying restricted stock units, which shares will vest in one installment on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on such date. |